Top Postbiotics Companies

The postbiotics market is projected to grow at a compound annual growth rate (CAGR) of 8.9% from 146.7 million in 2025 to 224.8 million by 2030. Increasing awareness among consumers regarding gut and immune health, coupled with the rise in demand for natural and functional products, will likely enhance the growth of postbiotics in the near future. Postbiotics are gaining increasing popularity, due to their stability and clinical evidence of safety and health benefits. As the food and beverage industries, and dietary supplements, are turning out to be proven methods to support the microbiome in shelf-stable forms, postbiotic use is on the rise. Emerging uses in skin health, metabolic regulation, and infant nutrition are further contributing to this market development and opening up new avenues in the human and animal sectors.

To know about the assumptions considered for the study download the pdf brochure

Partnerships between food tech, pharmaceutical, cosmetic, and pet food companies and microbiome researchers are accelerating the commercialization of new postbiotic formulations across different consumer bases- like in functional food & beverages, nutraceuticals, and skincare. Moreover, postbiotics have found a position as a reliable and versatile alternative to traditional probiotics. Postbiotics are expected to drive an industry boom in the future due to their increasing demand for stable shelf life and heat-processed products.

Market growth is driven by several factors, including rising consumer awareness of gut health and overall wellness, increasing incidence of digestive disorders and chronic health issues, and growing demand for functional foods and beverages. Awareness of the gut-brain-skin axis and the benefits of microbiome modulation is increasing, and postbiotics are slowly being projected as strong contenders in various fields, including food and bCargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), dsm-firmenich (Netherlands), Associated British Foods plc (UK), and BASF (Germany)everages, supplements, and personal care. Owing to their huge global presence, some of the major players in the postbiotics market include . Companies focus on a mix of organic and inorganic growth strategies such as partnerships, acquisitions, product launches, collaborations, and expansion of their facilities to better their market position and meet growing consumer demand globally. Scientific research, clinical validation, and advanced fermentation technologies are employed by these players to bolster their postbiotic offerings and create a stronghold in functional food, dietary supplements, personal care, and animal nutrition.

Cargill has become one of the largest privately held companies in the US, with a strong presence worldwide. The company is involved in the manufacturing and distribution of products for multiple sectors such as agriculture, animal nutrition, food & beverages, pharmaceuticals, bio-industrial, and food service. The company comprises multiple businesses classified into four key segments: Agricultural solutions, food, ingredients, and industrial products. Cargill produces a variety of supplements and functional ingredients for the growing needs of health and wellness. Among these supplements are the postbiotics, which are clinically shown to support immune health and positively modulate the gut microbiome; the efficacy of Cargill's postbiotics is well supported by research in robust ways.

Cargill opened its portals to the postbiotics market with the launch of its postbiotic product EpiCor in 2020. In a clinical study published in Pediatric Research in 2024, EpiCor proved beneficial for the immune health of children aged 4-12, showing less severe cold and flu-like symptoms with diminished dependence on medication. This was the first peer-reviewed study to assess the effectiveness of a postbiotic gummy in kids, solidifying Cargill's reputation for innovation in delivery formats. Beyond that, over 15 published investigation works have given Cargill additional credibility and increased stock availability, while it holds the Generally Recognized As Safe (GRAS) status approval and applications in human and pet nutrition to present a leading company for microbiome health solutions. Thus, the company is regarded as leading in microbiome health solutions.

Associated Archer Daniels Midland Company (ADM) is one of the worldwide leaders in nutrition across the full spectrum of science-based solutions in food, beverage, animal nutrition, health & wellness. ADM segments its business into four main sectors: Ag Services and Oilseeds; Carbohydrate Solutions; Nutrition; and Other Business. In its Nutrition segment, ADM has conducted impressive improvements in its biotics portfolio of probiotics, prebiotics, and postbiotics to meet the increasingly accelerating consumer demand for functional and health-supporting ingredients. ADM postbiotics, such as HT-BPL1 and HT-ES1 (Bifidobacterium longum CECT 7347), feature clinical studies supporting metabolic and digestive health benefits. In 2025, HT-ES1, the heat-treated postbiotic of ADM, won the Immune & Gut Health Ingredient category at the inaugural Vitafoods Europe Innovation Awards, showcasing ADM's relentless pursuit to offer stable, clinically proven microbiome solutions. Clinical trials have verified the efficacy of HT-ES1 in enhancing gut health and alleviating symptoms associated with irritable bowel syndrome (IBS).

Kerry Group plc is an Irish-headquartered global leader in taste and nutrition, providing innovative ingredient solutions for food, beverage, and pharmaceutical applications, all with an eye toward enhancing health and wellness through science-based, clean-label ingredients. Kerry has a geographical presence in over 140 countries across North America, Europe, South America, Asia Pacific, the Middle East, and Africa. It operates over 147 manufacturing sites in 32 countries across all six continents. Some of its major subsidiaries are Oakhouse Foods (UK), Island Oasis Inc (US), Sucrest GmbH (Germany), Ganeden (US), Big Train Inc (US), Oregon Chai (US), and Pevesa Biotech SA (Spain).

In February 2024, Kerry launched Plenibiotic, a clinically backed, rice-based postbiotics ingredient developed from Lactobacillus casei subsp. 327. Intended for human and pet supplements, the postbiotic Plenibiotic centers on the interaction of gut and skin, advocating digestive and skin health, which are areas of holistic wellness and healthy aging that are growing rapidly. This shelf-stable postbiotic is effective in low doses (50 mg for gut health, 100 mg for skin health) and is suitable for various supplement formats such as: capsules, powders, and gummies.

Market Ranking

The postbiotics market is driven by growing consumer demand for products that are scientifically validated, stable throughout their shelf life, and focused on promoting gut health. As a result, the postbiotics market is progressing to stay competitive in the food, beverage, and supplement sectors. Continuous product innovation, clinical research, and expansive strategies keep the market gripped by major companies like Cargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), dsm-firmenich (Netherlands), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), and Bioprox Healthcare (France). These elite companies have been using advanced fermentations, microbiome science, and strong supply chains in global functional ingredient markets. Their ability to serve diverse end-user industries—dietary supplements, functional beverages, infant nutrition, personal care, and animal health—gives them a great competitive advantage.

Smaller companies and even startups are riding on the emerging trend by integrating their ideas into postbiotics formulations or using novel strains and delivery formats. With a significantly limited market share, they contribute to market dynamism through innovative as well as agile operations, in addition to collaborations with research institutions. Their growth is expected to accelerate with increased investments, clinical validation, and strategic marketing efforts directed toward market entry.

Related Reports:

Postbiotics Market by Source (Bacteria, Yeast), Application (Functional Food & Beverages, Dietary Supplements, Animal Feed, Cosmetics & Personal Care, and Pharmaceuticals), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com